Thursday 25 Apr 2024
By
main news image

KUALA LUMPUR (May 15): Ho Wah Genting Bhd said its wholly-owned unit has been appointed as a distributor of a China-developed Covid-19 diagnostic kit in Malaysia, from today till year-end.

In a filing today, the group said HWG Consortium Sdn Bhd’s appointment was made by Shanghai Liangrun Biomedicine Technology Co Ltd.

“HWG Consortium has also submitted an application to the Ministry of Health, Malaysia for the certification of the diagnostic kit and is currently pending approval,” it said.

Additionally, HWG Consortium has also appointed PM Care Sdn Bhd as the non-exclusive sub-distributor of the diagnostic kit.

Shares in Ho Wah Genting fell 6 sen or 17.14% to 29 sen today, giving the group a market capitalisation of RM47.02 million.
 

      Print
      Text Size
      Share